Characterization and optimization of bilosomes for oral vaccine delivery

References

• Amorij JP, Westra TA, Hinrichs WL, Huckriede A, Frijlink HW. (2007). Towards an oral influenza vaccine: Comparison between intragastric and intracolonic delivery of influenza subunit vaccine in a murine model. Vaccine, 26, 67–76.
   PubMed Web of Science ®Google Scholar
• Azizi A, Kumar A, Diaz-Mitoma F, Mestecky J. (2010). Enhancing oral vaccine potency by targeting intestinal M cells. PLoS Pathog, 6, e1001147.
   PubMed Web of Science ®Google Scholar
• Bramwell VW, Perrie Y. (2005). The rational design of vaccines. Drug Discov Today, 10, 1527–1534.
   PubMed Web of Science ®Google Scholar
• Bramwell VW, Perrie Y. (2006). Particulate delivery systems for vaccines: What can we expect? J Pharm Pharmacol, 58, 717–728.
   PubMed Web of Science ®Google Scholar
• Chen, Y., Lu, Y., Chen, J., Lai, J., Sun, J., Hu, F., WU, W. 2009. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt International Journal of Pharmaceutics, 376, 153–160.
   PubMed Web of Science ®Google Scholar
• Conacher M, Alexander J, Brewer JM. (2001). Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes). Vaccine, 19, 2965–2974.
   PubMed Web of Science ®Google Scholar
• Devriendt B, De Geest BG, Goddeeris BM, Cox E. (2012). Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery. J Control Release, 160, 431–439.
   PubMed Web of Science ®Google Scholar
• Ebel JP. (1990). A method for quantifying particle absorption from the small intestine of the mouse. Pharm Res, 7, 848–851.
   PubMed Web of Science ®Google Scholar
• Eldridge JH, Hammond CJ, Meulbroek JA, Staas JK, Gilley RM, Tice TR. (1990). Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administered biodegradable microspheres target the peyer’s patches. J Contr Release, 11, 205–214.
   Web of Science ®Google Scholar
• Henriksen-Lacey M, Bramwell V, Perrie Y. (2010). Radiolabelling of antigen and liposomes for vaccine biodistribution studies. Pharmaceutics, 2, 91–104.
   Google Scholar
• Kogure K, Nakamura C, Okuda O, Hayashi K, Ueno M. (1997). Effect of dicetylphosphate or stearic acid on spontaneous transfer of protein from influenza virus-infected cells to dimyristoylphosphatidylcholine liposomes. Biochim Biophys Acta, 1329, 174–182.
   PubMed Web of Science ®Google Scholar
• Mann JF, Ferro VA, Mullen AB, Tetley L, Mullen M, Carter KC, Alexander J, Stimson WH. (2004). Optimisation of a lipid based oral delivery system containing A/Panama influenza haemagglutinin. Vaccine, 22, 2425–2429.
   PubMed Web of Science ®Google Scholar
• Mann JF, Scales HE, Shakir E, Alexander J, Carter KC, Mullen AB, Ferro VA. (2006). Oral delivery of tetanus toxoid using vesicles containing bile salts (bilosomes) induces significant systemic and mucosal immunity. Methods, 38, 90–95.
   PubMed Web of Science ®Google Scholar
• Mann JF, Shakir E, Carter KC, Mullen AB, Alexander J, Ferro VA. (2009). Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection. Vaccine, 27, 3643–3649.
   PubMed Web of Science ®Google Scholar
• Manosroi A, Wongtrakul P, Manosroi J, Sakai H, Sugawara F, Yuasa M, Abe M. (2003). Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids and Surfaces B: Biointerfaces, 30, 129–138.
   Web of Science ®Google Scholar
• Norris DA, Puri N, Sinko PJ. (1998). The effect of physical barriers and properties on the oral absorption of particulates. Adv Drug Deliv Rev, 34, 135–154.
   PubMed Web of Science ®Google Scholar
• Schmucker DL, Heyworth MF, Owen RL, Daniels CK. (1996). Impact of aging on gastrointestinal mucosal immunity. Dig Dis Sci, 41, 1183–1193.
   PubMed Web of Science ®Google Scholar
• Schubert R, Jaroni H, Schoelmerich J, Schmidt KH. (1983). Studies on the mechanism of bile salt-induced liposomal membrane damage. Digestion, 28, 181–190.
   PubMed Web of Science ®Google Scholar
• Shukla A, Khatri K, Gupta PN, Goyal AK, Mehta A, Vyas SP. (2008). Oral immunization against hepatitis B using bile salt stabilized vesicles (bilosomes). J Pharm Pharm Sci, 11, 59–66.
   PubMed Web of Science ®Google Scholar
• Shukla A, Katare OP, Singh B, Vyas SP. (2010). M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes. Int J Pharm, 385, 47–52.
   PubMed Web of Science ®Google Scholar
• Shukla A, Singh B, Katare OP. (2011). Significant systemic and mucosal immune response induced on oral delivery of diphtheria toxoid using nano-bilosomes. Br J Pharmacol, 164, 820–827.
   PubMed Web of Science ®Google Scholar
• Tomizawa H, Aramaki Y, Fujii Y, Hara T, Suzuki N, Yachi K, Kikuchi H, Tsuchiya S. (1993). Uptake of phosphatidylserine liposomes by rat Peyer’s patches following intraluminal administration. Pharm Res, 10, 549–552.
   PubMed Web of Science ®Google Scholar
• Vertzoni M, Dressman J, Butler J, Hempenstall J, Reppas C. (2005). Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds. Eur J Pharm Biopharm, 60, 413–417.
   PubMed Web of Science ®Google Scholar
• Wilkhu J, McNeil SE, Kirby DJ, Perrie Y. (2011). Formulation design considerations for oral vaccines. Ther Deliv, 2, 1141–1164.
   PubMedGoogle Scholar